Literature DB >> 2398432

Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors.

D K Cooper1.   

Abstract

A clinical survey of 4895 heart transplants performed at 66 centers worldwide revealed that eight patients (0.16%) had received ABO-incompatible donor hearts. Of these eight transplants, five hearts (63%) were hyperacutely rejected (vascular or humoral rejection), four within 24 hours and one (after treatment by plasmapheresis) at 13 days. Two patients died at the time of rejection; the remaining three underwent retransplantation. Two patients died (at retransplant and at 7 weeks, respectively), and one is alive 8 months later. Three ABO-incompatible hearts (37%) were not hyperacutely rejected; two of these patients remain alive 12 and 26 months later, and the third died at 11 months in an automobile accident. There was, therefore, an early mortality of four of eight patients (50%). Care should be taken to ensure ABO compatibility of the donor whenever heart transplantation is undertaken.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2398432

Source DB:  PubMed          Journal:  J Heart Transplant        ISSN: 0887-2570


  8 in total

Review 1.  Immunogenicity and allogenicity: a challenge of stem cell therapy.

Authors:  Dominique Charron; Caroline Suberbielle-Boissel; Reem Al-Daccak
Journal:  J Cardiovasc Transl Res       Date:  2008-09-26       Impact factor: 4.132

Review 2.  How to cross immunogenetic hurdles to human embryonic stem cell transplantation.

Authors:  Casimir de Rham; Jean Villard
Journal:  Semin Immunopathol       Date:  2011-04-02       Impact factor: 9.623

Review 3.  Immunological considerations for embryonic and induced pluripotent stem cell banking.

Authors:  Craig J Taylor; Eleanor M Bolton; J Andrew Bradley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2011-08-12       Impact factor: 6.237

4.  Blood Group A antigen expression on cardiac endothelium is highly individualized: possible implications for transplantation.

Authors:  Eric A Gehrie; Justin M Cates; Hui Nian; Sandy J Olson; Pampee P Young
Journal:  Cardiovasc Pathol       Date:  2013-01-04       Impact factor: 2.185

5.  And justice for all: consideration of ABO compatibility in allocation of hearts for infant transplantation.

Authors:  Lori J West; Jeffrey L Platt
Journal:  Circulation       Date:  2010-04-19       Impact factor: 29.690

6.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

Review 7.  Modifying the sugar icing on the transplantation cake.

Authors:  David K C Cooper
Journal:  Glycobiology       Date:  2016-03-01       Impact factor: 4.313

Review 8.  The immune boundaries for stem cell based therapies: problems and prospective solutions.

Authors:  Abdelkrim Hmadcha; Hmadcha Abdelkrim; Juan Domínguez-Bendala; Domínguez-Bendala Juan; Jane Wakeman; Wakeman Jane; Mohamed Arredouani; Arredouani Mohamed; Bernat Soria; Soria Bernat
Journal:  J Cell Mol Med       Date:  2009-07-06       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.